LABD vs. TMF
LABD (Direxion Daily S&P Biotech Bear 3x Shares) and TMF (Direxion Daily 20+ Year Treasury Bull 3X ETF) are both exchange-traded funds - LABD is a Leveraged Equities fund tracking the S&P Biotechnology Select Industry Index (-300%), while TMF is a Leveraged Bonds fund tracking the ICE U.S. Treasury 20+ Year Bond Index (300%). Both are passively managed. Over the past 10 years, LABD returned -59.09%/yr vs -16.87%/yr for TMF. At a 0.04 correlation, their price movements are largely independent. LABD charges 1.06%/yr vs 1.01%/yr for TMF.
Performance
LABD vs. TMF - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, LABD achieves a -53.78% return, which is significantly lower than TMF's -4.67% return. Over the past 10 years, LABD has underperformed TMF with an annualized return of -59.09%, while TMF has yielded a comparatively higher -16.87% annualized return.
LABD
- 1D
- -3.10%
- 1M
- -32.29%
- YTD
- -53.78%
- 6M
- -50.39%
- 1Y
- -87.04%
- 3Y*
- -56.99%
- 5Y*
- -43.25%
- 10Y*
- -59.09%
TMF
- 1D
- -0.62%
- 1M
- 4.96%
- YTD
- -4.67%
- 6M
- -5.95%
- 1Y
- -2.80%
- 3Y*
- -21.07%
- 5Y*
- -31.33%
- 10Y*
- -16.87%
LABD vs. TMF - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
LABD Direxion Daily S&P Biotech Bear 3x Shares | -53.78% | -70.07% | -21.43% | -41.77% | -32.68% | 1.86% | -89.75% | -70.80% | -6.26% | -75.67% |
TMF Direxion Daily 20+ Year Treasury Bull 3X ETF | -4.67% | -2.94% | -35.95% | -13.01% | -72.60% | -19.80% | 39.02% | 34.75% | -11.01% | 22.72% |
Correlation
The correlation between LABD and TMF is -0.22, meaning they tend to move in opposite directions. This is especially valuable for risk management - when one declines, the other has historically tended to hold steady or rise.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | -0.22 |
Correlation (3Y) Calculated over the trailing 3-year period | -0.23 |
Correlation (5Y) Calculated over the trailing 5-year period | -0.12 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.01 |
Correlation (All Time) Calculated using the full available price history since May 28, 2015 | 0.04 |
The correlation between LABD and TMF shifts across timeframes, from -0.23 (3 years) to 0.04 (all time), reflecting how their relationship changes across market environments.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
LABD vs. TMF — Risk / Return Rank
LABD
TMF
LABD vs. TMF - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Direxion Daily S&P Biotech Bear 3x Shares (LABD) and Direxion Daily 20+ Year Treasury Bull 3X ETF (TMF). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| LABD | TMF | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -1.01 | ||
| Sortino ratioReturn per unit of downside risk | -2.78 | ||
| Omega ratioGain probability vs. loss probability | 0.70 | 1.01 | -0.31 |
| Calmar ratioReturn relative to maximum drawdown | -1.00 | -0.11 | -0.90 |
| Martin ratioReturn relative to average drawdown | -1.37 | -0.23 | -1.14 |
Loading charts...
Drawdowns
LABD vs. TMF - Drawdown Comparison
The maximum LABD drawdown since its inception was -99.99%, which is greater than TMF's maximum drawdown of -92.89%. Use the drawdown chart below to compare losses from any high point for LABD and TMF.
Loading charts...
Drawdown Indicators
| LABD | TMF | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -99.99% | -92.89% | -7.10% |
Max Drawdown (1Y)Largest decline over 1 year | -86.75% | -26.51% | -60.24% |
Max Drawdown (3Y)Largest decline over 3 years | -96.40% | -56.09% | -40.31% |
Max Drawdown (5Y)Largest decline over 5 years | -98.65% | -88.81% | -9.84% |
Max Drawdown (10Y)Largest decline over 10 years | -99.99% | -92.89% | -7.10% |
Current DrawdownCurrent decline from peak | -99.99% | -92.11% | -7.88% |
Average DrawdownAverage peak-to-trough decline | -90.99% | -43.76% | -47.23% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 64.00% | 12.26% | +51.74% |
Volatility
LABD vs. TMF - Volatility Comparison
Direxion Daily S&P Biotech Bear 3x Shares (LABD) has a higher volatility of 29.98% compared to Direxion Daily 20+ Year Treasury Bull 3X ETF (TMF) at 6.50%. This indicates that LABD's price experiences larger fluctuations and is considered to be riskier than TMF based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| LABD | TMF | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 29.98% | 6.50% | +23.48% |
Volatility (6M)Calculated over the trailing 6-month period | 65.23% | 19.35% | +45.88% |
Volatility (1Y)Calculated over the trailing 1-year period | 78.79% | 27.91% | +50.88% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 96.66% | 46.59% | +50.07% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 95.97% | 43.86% | +52.11% |
LABD vs. TMF - Expense Ratio Comparison
LABD has a 1.06% expense ratio, which is higher than TMF's 1.01% expense ratio.
Dividends
LABD vs. TMF - Dividend Comparison
LABD's dividend yield for the trailing twelve months is around 9.79%, more than TMF's 4.09% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
LABD Direxion Daily S&P Biotech Bear 3x Shares | 9.79% | 6.67% | 4.68% | 6.13% | 0.53% | 0.00% | 3.94% | 1.75% | 0.81% | 0.00% |
TMF Direxion Daily 20+ Year Treasury Bull 3X ETF | 4.09% | 4.06% | 4.29% | 2.82% | 1.62% | 0.13% | 2.23% | 0.94% | 1.49% | 0.41% |
Frequently Asked Questions
LABD and TMF have a correlation of -0.22, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
LABD has higher volatility (29.98%) compared to TMF (6.50%). In terms of maximum drawdown, LABD dropped -99.99% vs TMF's -92.89%.
On 10-year performance, TMF leads with -16.87% vs -59.09% for LABD. On fees, TMF is cheaper at 1.01% per year. On volatility, TMF has been the lower-risk option at 6.50%. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 10-year period, TMF has performed better with a -16.87% return vs -59.09%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
TMF is cheaper with a 1.01% expense ratio, compared with 1.06% for LABD.
LABD has the higher dividend yield at 9.79%, compared with 4.09% for TMF.
LABD is categorized as Leveraged Equities, while TMF is Leveraged Bonds. LABD tracks S&P Biotechnology Select Industry Index (-300%), while TMF tracks ICE U.S. Treasury 20+ Year Bond Index (300%). Their fees differ too: 1.06% for LABD and 1.01% for TMF.
TMF currently has the higher Sharpe Ratio (-0.10 vs -1.11), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for LABD and TMF
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer